CME Group Inc (0HR2.L)

Name: CME Group Inc Financial Statements
Creator: Quarter Results

Financial Services | Financial Diversified

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$1.9B

Net Income

$1.2B

Operating Margin

69.7%

Free Cash Flow

$4.2B

Debt / Assets

85.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for CME Group Inc (0HR2.L).
Income Statement (Quarterly)	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	1,880,100,000	1,648,700,000	1,537,600,000	1,692,000,000
Cost of Revenue	223,000,000	241,100,000	237,600,000	221,600,000
Gross Profit	1,657,100,000	1,407,600,000	1,300,000,000	1,470,400,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	28,200,000	47,900,000	36,700,000	37,400,000
Operating Expenses	347,400,000	388,000,000	327,400,000	341,100,000
Operating Income	1,309,700,000	1,019,600,000	972,600,000	1,129,300,000
Interest Expense	43,600,000	0	44,000,000	44,000,000
Income Before Tax	1,510,900,000	1,578,400,000	1,177,000,000	1,330,300,000
Income Tax Expense	356,600,000	410,400,000	269,000,000	305,200,000
Net Income	1,154,300,000	1,168,000,000	908,000,000	1,012,200,000
Per Share
EPS	3.25	3.25	2.49	2.81
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for CME Group Inc (0HR2.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	6,520,600,000	6,130,100,000	5,578,900,000	5,019,400,000
Cost of Revenue	907,000,000	850,300,000	828,600,000	1,008,600,000
Gross Profit	5,613,600,000	5,279,800,000	4,750,300,000	4,010,800,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	150,500,000	132,700,000	144,400,000	1,456,400,000
Operating Expenses	1,384,100,000	1,348,300,000	1,314,600,000	994,900,000
Operating Income	4,229,500,000	3,931,500,000	3,435,700,000	3,015,900,000
Interest Expense	129,700,000	160,900,000	159,400,000	162,700,000
Income Before Tax	5,330,500,000	4,541,400,000	4,153,600,000	3,490,300,000
Income Tax Expense	1,273,200,000	1,015,600,000	927,400,000	799,300,000
Net Income	4,044,400,000	3,525,800,000	3,226,200,000	2,696,100,000
Per Share
EPS	11.18	9.69	8.87	7.51
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for CME Group Inc (0HR2.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	4,423,400,000	2,892,400,000	2,912,000,000	2,725,000,000
Short Term Investments	125,000,000	113,200,000	111,700,000	96,000,000
Net Receivables	639,200,000	573,100,000	535,600,000	483,200,000
Inventory	0	0	0	1
Total Current Assets	5,187,600,000	103,033,500,000	94,890,200,000	139,078,300,000
Property Plant Equipment	573,000,000	386,200,000	744,300,000	766,100,000
Goodwill and Intangibles	30,300,700,000	30,483,800,000	30,720,800,000	30,927,500,000
Total Assets	198,548,400,000	137,447,000,000	129,706,100,000	174,314,200,000
Liabilities
Account Payables	71,800,000	79,900,000	90,600,000	121,400,000
Short Term Debt	55,800,000	749,800,000	55,100,000	74,100,000
Total Current Liabilities	55,800,000	102,313,900,000	93,416,900,000	137,687,500,000
Long Term Debt	3,701,400,000	2,678,200,000	3,828,800,000	3,422,400,000
Total Liabilities	169,820,200,000	110,960,100,000	102,968,200,000	147,435,500,000
Shareholders Equity
Retained Earnings	6,433,200,000	4,185,800,000	4,455,200,000	4,746,800,000
Total Shareholders Equity	28,728,200,000	26,486,900,000	26,737,900,000	26,878,700,000

Balance sheet annual history for CME Group Inc (0HR2.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	4,423,400,000	2,892,400,000	2,912,000,000	2,725,000,000
Short Term Investments	125,000,000	113,200,000	111,700,000	96,000,000
Net Receivables	639,200,000	573,100,000	535,600,000	483,200,000
Inventory	0	0	0	1
Total Current Assets	5,187,600,000	103,033,500,000	94,890,200,000	139,078,300,000
Property Plant Equipment	573,000,000	386,200,000	744,300,000	766,100,000
Goodwill and Intangibles	30,300,700,000	30,483,800,000	30,720,800,000	30,927,500,000
Total Assets	198,548,400,000	137,447,000,000	129,706,100,000	174,314,200,000
Liabilities
Account Payables	71,800,000	79,900,000	90,600,000	121,400,000
Short Term Debt	55,800,000	749,800,000	55,100,000	74,100,000
Total Current Liabilities	55,800,000	102,313,900,000	93,416,900,000	137,687,500,000
Long Term Debt	3,701,400,000	2,678,200,000	3,828,800,000	3,422,400,000
Total Liabilities	169,820,200,000	110,960,100,000	102,968,200,000	147,435,500,000
Shareholders Equity
Retained Earnings	6,433,200,000	4,185,800,000	4,455,200,000	4,746,800,000
Total Shareholders Equity	28,728,200,000	26,486,900,000	26,737,900,000	26,878,700,000

Cash flow quarterly history for CME Group Inc (0HR2.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	4,044,400,000	3,525,800,000	3,226,200,000	2,696,100,000
Depreciation & Amortization	223,400,000	336,800,000	352,600,000	362,600,000
Stock Based Compensation	94,800,000	89,500,000	82,900,000	84,800,000
Change in Working Capital	138,100,000	-191,600,000	-95,200,000	-53,900,000
Operating Cash Flow	4,277,100,000	3,690,500,000	3,453,800,000	3,056,000,000
Investing Activities
Capital Expenditure	-83,500,000	-94,000,000	-76,400,000	-89,700,000
Investments	-83,500,000	-94,000,000	-76,400,000	-89,700,000
Investing Cash Flow	1,498,800,000	-82,600,000	20,900,000	-489,800,000
Financing Activities
Debt Repayment	-9,399,999	0	-16,400,000	-15,200,000
Common Stock Issued/Repurchased	-266,100,000	-33,000,000	-21,400,000	756,200,000
Dividends Paid	-3,933,000,000	-3,584,200,000	-3,235,500,000	-2,633,500,000
Financing Cash Flow	56,509,500,000	5,076,500,000	-48,339,300,000	-25,381,700,000
Summary
Free Cash Flow	4,193,600,000	3,596,500,000	3,377,400,000	2,966,300,000
Net Change in Cash	1,524,700,000	8,684,400,000	-44,864,600,000	-114,700,000

Cash flow annual history for CME Group Inc (0HR2.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	4,044,400,000	3,525,800,000	3,226,200,000	2,696,100,000
Depreciation & Amortization	223,400,000	336,800,000	352,600,000	362,600,000
Stock Based Compensation	94,800,000	89,500,000	82,900,000	84,800,000
Change in Working Capital	138,100,000	-191,600,000	-95,200,000	-53,900,000
Operating Cash Flow	4,277,100,000	3,690,500,000	3,453,800,000	3,056,000,000
Investing Activities
Capital Expenditure	-83,500,000	-94,000,000	-76,400,000	-89,700,000
Investments	-83,500,000	-94,000,000	-76,400,000	-89,700,000
Investing Cash Flow	1,498,800,000	-82,600,000	20,900,000	-489,800,000
Financing Activities
Debt Repayment	-9,399,999	0	-16,400,000	-15,200,000
Common Stock Issued/Repurchased	-266,100,000	-33,000,000	-21,400,000	756,200,000
Dividends Paid	-3,933,000,000	-3,584,200,000	-3,235,500,000	-2,633,500,000
Financing Cash Flow	56,509,500,000	5,076,500,000	-48,339,300,000	-25,381,700,000
Summary
Free Cash Flow	4,193,600,000	3,596,500,000	3,377,400,000	2,966,300,000
Net Change in Cash	1,524,700,000	8,684,400,000	-44,864,600,000	-114,700,000